These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33547864)

  • 1. Acute isolated trigeminal neuropathy following calcium hydroxylapatite-based soft tissue filler injection: A case report.
    Mingazova L; Karpova E; Murakov S; Orlova O; Golubev V; Cotofana S
    J Cosmet Dermatol; 2021 May; 20(5):1505-1511. PubMed ID: 33547864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case report of ophthalmic artery emboli secondary to Calcium Hydroxylapatite filler injection for nose augmentation- long-term outcome.
    Cohen E; Yatziv Y; Leibovitch I; Kesler A; Cnaan RB; Klein A; Goldenberg D; Habot-Wilner Z
    BMC Ophthalmol; 2016 Jul; 16():98. PubMed ID: 27391691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing intravascular complications following treatment with calcium hydroxylapatite: An expert consensus.
    van Loghem J; Funt D; Pavicic T; Goldie K; Yutskovskaya Y; Fabi S; Siebenga P; Thuis J; Hkeik J; Kadouch J; Prager W; Azib N; Casabona G; Dayan S; Bay Aguilera S; Snozzi P; Saeed P
    J Cosmet Dermatol; 2020 Nov; 19(11):2845-2858. PubMed ID: 32185876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choroid vascular occlusion and ischemic optic neuropathy after facial calcium hydroxyapatite injection- a case report.
    Chou CC; Chen HH; Tsai YY; Li YL; Lin HJ
    BMC Surg; 2015 Mar; 15():21. PubMed ID: 25884651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A problem-oriented approach to nodular complications from hyaluronic acid and calcium hydroxylapatite fillers: classification and recommendations for treatment.
    Cassuto D; Sundaram H
    Plast Reconstr Surg; 2013 Oct; 132(4 Suppl 2):48S-58S. PubMed ID: 24077011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of impending necrosis associated with soft tissue filler injections.
    Dayan SH; Arkins JP; Mathison CC
    J Drugs Dermatol; 2011 Sep; 10(9):1007-12. PubMed ID: 22052269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subperiosteal injections during facial soft tissue filler injections-Is it possible?
    Pavicic T; Yankova M; Schenck TL; Frank K; Freytag DL; Sykes J; Green JB; Hamade H; Casabona G; Cotofana S
    J Cosmet Dermatol; 2020 Mar; 19(3):590-595. PubMed ID: 31310047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eyelid mass secondary to injection of calcium hydroxylapatite facial filler.
    Lee MJ; Sung MS; Kim NJ; Choung HK; Khwarg SI
    Ophthalmic Plast Reconstr Surg; 2008; 24(5):421-3. PubMed ID: 18806674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation.
    Jansen DA; Graivier MH
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):22S-30S, discussion 31S-33S. PubMed ID: 16936541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of Filler Emboli as a Mechanism for Filler-Related Blindness.
    Ugradar S; Diniz S; Hoenig J; Goldberg RA
    Dermatol Surg; 2021 Feb; 47(2):235-237. PubMed ID: 33273358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light Perception Vision Recovery After Treatment for Calcium Hydroxylapatite Cosmetic Filler-Induced Blindness.
    Vu PQ; Grob SR; Tao JP
    Ophthalmic Plast Reconstr Surg; 2018; 34(6):e189-e192. PubMed ID: 30234833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium hydroxylapatite associated soft tissue necrosis: a case report and treatment guideline.
    Tracy L; Ridgway J; Nelson JS; Lowe N; Wong B
    J Plast Reconstr Aesthet Surg; 2014 Apr; 67(4):564-8. PubMed ID: 23993752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual loss following cosmetic facial filler injection.
    Shoughy SS
    Arq Bras Oftalmol; 2019; 82(6):511-513. PubMed ID: 31531542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular complications of soft tissue filler injections: A review of literature.
    Lee W; Koh IS; Oh W; Yang EJ
    J Cosmet Dermatol; 2020 Apr; 19(4):772-781. PubMed ID: 31709739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications associated with injectable soft-tissue fillers: a 5-year retrospective review.
    Daines SM; Williams EF
    JAMA Facial Plast Surg; 2013 May; 15(3):226-31. PubMed ID: 23539246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium hydroxylapatite filler: an overview of safety and tolerability.
    Pavicic T
    J Drugs Dermatol; 2013 Sep; 12(9):996-1002. PubMed ID: 24002146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in Nasal Sensibility Following Calcium Hydroxyapatite Dorsal Augmentation.
    Alharethy S
    J Craniofac Surg; 2018 Mar; 29(2):e104-e106. PubMed ID: 29068971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of calcium hydroxylapatite in the upper third of the face: Retrospective analysis of techniques, dilutions and adverse events.
    Van Loghem JAJ
    J Cosmet Dermatol; 2018 Dec; 17(6):1025-1030. PubMed ID: 30362225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technique for calcium hydroxylapatite injection for correction of nasolabial fold depressions.
    Alam M; Yoo SS
    J Am Acad Dermatol; 2007 Feb; 56(2):285-9. PubMed ID: 17224371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-lasting results with hydroxylapatite (Radiesse) facial filler.
    Jacovella PF; Peiretti CB; Cunille D; Salzamendi M; Schechtel SA
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):15S-21S. PubMed ID: 16936540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.